Sinonasal CT scores were associated with several prognostic features in the disease course of chronic rhinosinusitis with nasal polyps, including blood eosinophil counts and risk of relapse after endoscopic sinus surgery.
Prognostic features and treatment outcomes in chronic rhinosinusitis with nasal polyps (CRSwNP) may be predicted by sinonasal CT scores, according to study findings published in Tomography.
In understanding the pathophysiology of CRSwNP, rhinologists consider the condition to consist of several endotypes that differ in disease recurrence risk and require targeted follow-up protocols and postoperative treatments.
With CT serving as the most common imaging modality in CRSwNP for the evaluation of inflammatory sinus mucosal disease, the present authors sought to assess whether it could predict the relationship of sinonasal inflammatory involvement with the clinical, laboratory, histopathological, and prognostic features of the condition.
Researchers used the Lund–Mackay score (LMS), the most widely applied CT staging system of sinonasal inflammatory changes, to examine in 78 patients the relationship with CRSwNP prior to and following endoscopic sinus surgery (ESS). Single paranasal subsite (maxillary, ethmoid, frontal, and sphenoid) and ostiomeatal complex (OMC) scores identified by the CT were also evaluated.
“Because of CT high spatial resolution and ability to depict fine osseous detail, it is the imaging test of choice for providing the necessary information for ESS planning,” they explained. “Such as the presence of fluid and degree of mucosal thickening, the presence of bone dehiscence or osteitis, and the anatomy of the sinuses, including important sinonasal anatomic variants.”
After assessing the association of LMS with clinical features, univariate logistic regression analysis findings indicated that ethmoid (odds ratio [OR], 1.358; P = .0496), sphenoid (OR, 1.722; P = .0335), OMC (OR, 1.706; P = .0235), and frontal (OR, 1.742; P = .0164) CT scores were predictive of nonsteroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (NERD), which was confirmed via the total CT score (OR, 1.193; P = .0062).
No significant differences were shown between patients with and without allergy regarding total and partial CT scores.
Regarding the association of LMS with laboratory results, high blood eosinophil counts (> 0.24 vs ≤ 0.24 cells × 10,9/L) were associated with total (OR, 1.106; P = .0213), maxillary (OR, 1.729; P = 0.0227) and ethmoid (OR, 1.200; P = .0491) CT scores in the univariate analysis. Moreover, higher ethmoid (OR, 1.399; P = .0006) and total sinonasal (OR, 1.142; P = .0027) CT scores were found to predict histopathologically eosinophil CRSwNPs.
“CT scores did not result as predictive of NSAID-exacerbated respiratory disease, asthma, or blood eosinophil count at the multivariate analysis,” noted the researchers.
Risk of relapse was also found to be related to the presence of NERD (HR, 3.914; 95% CI, 1.232-12.435; P = .0207), higher preoperative total score (HR, 1.098 95% CI, 1.001-1.204; P = .0486), and frontal sinus CT score (HR, 1.555; 95% CI, 1.006-1.886; P = .0218), but these results were not confirmed by the multivariable analysis.
“The preoperative sinonasal CT variables considered herein should be further investigated for their potential as a valuable aid in providing patients with correct information about prognosis and, mainly, to avoid generic treatments with poor outcomes,” concluded the study authors.
Reference
Brescia G, Contro G, Ruaro A, Frigo AC, Barion U, Marioni G. Preoperative sinonasal computed tomography score in chronic rhinosinusitis with nasal polyps. Tomography. 2022;8(1):77-88. doi:10.3390/tomography8010007
Dr Kathy Zackowski Discusses the Importance of Rehabilitation Research and Trials in MS
April 26th 2024Kathy Zackowski, PhD, National MS Society, expresses the inherent value of quality rehabilitation trials for broadening clinical understandings of multiple sclerosis (MS) and bettering patient outcomes.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More